TransMedics Group Gross Profit Growth & History (TMDX)
TransMedics Group's gross profit was $362.8M for fiscal 2025.
View full TransMedics Group company overviewTransMedics Group annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $362.8M | $100.7M | +38.43% |
| 2024 | 2024-12-31 | $262.1M | $108.0M | +70.08% |
| 2023 | 2023-12-31 | $154.1M | $88.8M | +136.08% |
| 2022 | 2022-12-31 | $65.3M | $44.1M | +208.48% |
| 2021 | 2021-12-31 | $21.2M | $4.5M | +27.20% |
| 2020 | 2020-12-31 | $16.6M | $2.8M | +20.00% |
| 2019 | 2019-12-28 | $13.9M | $8.1M | +141.77% |
| 2018 | 2018-12-29 | $5.7M | — | — |
TransMedics Group quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $113.2M | $16.6M | +17.20% |
| Q1 2026 | 2026-03-31 | $101.2M | $12.9M | +14.66% |
| Q4 2025 | 2025-12-31 | $93.4M | $21.4M | +29.72% |
| Q3 2025 | 2025-09-30 | $84.6M | $23.7M | +39.00% |
| Q2 2025 | 2025-06-30 | $96.6M | $27.3M | +39.46% |
| Q1 2025 | 2025-03-31 | $88.2M | $28.3M | +47.14% |
| Q4 2024 | 2024-12-31 | $72.0M | $24.1M | +50.27% |
| Q3 2024 | 2024-09-30 | $60.8M | $20.2M | +49.64% |
| Q2 2024 | 2024-06-30 | $69.3M | $32.5M | +88.51% |
| Q1 2024 | 2024-03-31 | $60.0M | $31.2M | +108.45% |
| Q4 2023 | 2023-12-31 | $47.9M | $27.2M | +131.48% |
| Q3 2023 | 2023-09-30 | $40.7M | $22.5M | +124.47% |
| Q2 2023 | 2023-06-30 | $36.7M | $22.4M | +156.03% |
| Q1 2023 | 2023-03-31 | $28.8M | $16.7M | +137.66% |
| Q4 2022 | 2022-12-31 | $20.7M | $13.7M | +196.35% |
| Q3 2022 | 2022-09-30 | $18.1M | $14.3M | +380.12% |
| Q2 2022 | 2022-06-30 | $14.3M | $8.8M | +156.75% |
| Q1 2022 | 2022-03-31 | $12.1M | $7.3M | +151.59% |
| Q4 2021 | 2021-12-31 | $7.0M | $2.2M | +44.70% |
| Q3 2021 | 2021-09-30 | $3.8M | −$1.3M | −25.11% |
| Q2 2021 | 2021-06-30 | $5.6M | $3.7M | +192.77% |
| Q1 2021 | 2021-03-31 | $4.8M | −$49,000 | −1.01% |
| Q4 2020 | 2020-12-31 | $4.8M | $1.1M | +29.06% |
| Q3 2020 | 2020-09-30 | $5.0M | $822,000 | +19.50% |
| Q2 2020 | 2020-06-30 | $1.9M | −$1.4M | −42.72% |
| Q1 2020 | 2020-03-31 | $4.9M | $2.3M | +88.88% |
| Q4 2019 | 2019-12-28 | $3.7M | $2.2M | +149.57% |
| Q3 2019 | 2019-09-28 | $4.2M | $2.1M | +97.75% |
| Q2 2019 | 2019-06-29 | $3.3M | $2.2M | +182.70% |
| Q1 2019 · Mar 30 | 2019-03-30 | $2.6M | $1.6M | +178.46% |
| Q4 2018 | 2018-12-29 | $1.5M | — | — |
| Q3 2018 | 2018-09-29 | $2.1M | — | — |
| Q2 2018 | 2018-06-30 | $1.2M | — | — |
| Q1 2018 | 2018-03-31 | $924,000 | — | — |
TransMedics Group gross profit trends
Over the last five fiscal years, TransMedics Group's gross profit increased from $16.6M to $362.8M, a change of $346.2M. The latest reported quarter, Q2 2026, shows $113.2M.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TransMedics Group source filings ↗